GLAS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 28 of 33 cases where GLAS's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 85%.
The RSI Indicator shows that the ticker has stayed in the oversold zone for 19 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Moving Average Convergence Divergence Histogram (MACD) for GLAS turned negative on September 24, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 35 similar instances when the indicator turned negative. In 31 of the 35 cases the stock turned lower in the days that followed. This puts the odds of success at 89%.
The 50-day moving average for GLAS moved below the 200-day moving average on September 23, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where GLAS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.
The Aroon Indicator for GLAS entered a downward trend on October 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 6 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 39 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.023) is normal, around the industry mean (11.138). P/E Ratio (-3.066) is within average values for comparable stocks, (-7.600). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.152). Dividend Yield (0.000) settles around the average of (0.038) among similar stocks. P/S Ratio (3.880) is also within normal values, averaging (178.797).
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 97 (best 1 - 100 worst), indicating slightly worse than average price growth. GLAS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GLAS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.
On October 19, 2026, the Stochastic Oscillator for TRLV moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 65 instances where the indicator left the oversold zone. In 54 of the 65 cases the stock moved higher in the following days. This puts the odds of a move higher at over 83%.
The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on TRLV as a result. In 68 of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 78%.
Following a +7.00% 3-day Advance, the price is estimated to grow further. Considering data from situations where TRLV advanced for three days, in 188 of 233 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
TRLV moved below its 50-day moving average on October 08, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for TRLV crossed bearishly below the 50-day moving average on October 12, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 15 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TRLV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.
The Aroon Indicator for TRLV entered a downward trend on October 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Price Growth Rating for this company is 39 (best 1 - 100 worst), indicating steady price growth. TRLV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 48 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.760) is normal, around the industry mean (11.138). P/E Ratio (-4.453) is within average values for comparable stocks, (-7.600). Projected Growth (PEG Ratio) (0.470) is also within normal values, averaging (2.152). Dividend Yield (0.000) settles around the average of (0.038) among similar stocks. P/S Ratio (1.947) is also within normal values, averaging (178.797).
The Tickeron PE Growth Rating for this company is 69 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TRLV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.
GLAS | TRLV | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 51 | 82 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 39 Fair valued | 48 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 98 | 98 | |
PRICE GROWTH RATING 1..100 | 97 | 39 | |
P/E GROWTH RATING 1..100 | 6 | 69 | |
SEASONALITY SCORE 1..100 | 50 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
GLAS's Valuation (39) in the null industry is in the same range as TRLV (48). This means that GLAS’s stock grew similarly to TRLV’s over the last 12 months.
GLAS's Profit vs Risk Rating (100) in the null industry is in the same range as TRLV (100). This means that GLAS’s stock grew similarly to TRLV’s over the last 12 months.
GLAS's SMR Rating (98) in the null industry is in the same range as TRLV (98). This means that GLAS’s stock grew similarly to TRLV’s over the last 12 months.
TRLV's Price Growth Rating (39) in the null industry is somewhat better than the same rating for GLAS (97). This means that TRLV’s stock grew somewhat faster than GLAS’s over the last 12 months.
GLAS's P/E Growth Rating (6) in the null industry is somewhat better than the same rating for TRLV (69). This means that GLAS’s stock grew somewhat faster than TRLV’s over the last 12 months.
| GLAS | TRLV | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 81% | N/A |
| Stochastic ODDS (%) | N/A | 2 days ago 83% |
| Momentum ODDS (%) | N/A | 2 days ago 78% |
| MACD ODDS (%) | 2 days ago 89% | N/A |
| TrendWeek ODDS (%) | 2 days ago 88% | 2 days ago 83% |
| TrendMonth ODDS (%) | 2 days ago 89% | 2 days ago 84% |
| Advances ODDS (%) | N/A | 2 days ago 81% |
| Declines ODDS (%) | 2 days ago 88% | 9 days ago 86% |
| BollingerBands ODDS (%) | 2 days ago 85% | N/A |
| Aroon ODDS (%) | 2 days ago 87% | 2 days ago 77% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
GLAS’s FA Score shows that 1 FA rating(s) are green while TRLV’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
GLAS’s TA Score shows that 2 TA indicator(s) are bullish while TRLV’s TA Score has 3 bullish TA indicator(s).
GLAS (@Pharmaceuticals: Generic) experienced а -36.86% price change this week, while TRLV (@Pharmaceuticals: Generic) price change was +10.33% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -2.94%. For the same industry, the average monthly price growth was -9.84%, and the average quarterly price growth was +9.53%.
GLAS is expected to report earnings on Nov 11, 2026.
TRLV is expected to report earnings on Nov 05, 2026.
A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.
A.I.dvisor indicates that over the last year, GLAS has been closely correlated with TRLV. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if GLAS jumps, then TRLV could also see price increases.
| Ticker / NAME | Correlation To GLAS | 1D Price Change % | ||
|---|---|---|---|---|
| GLAS | 100% | -0.43% | ||
| TRLV - GLAS | 69% Closely correlated | +1.95% | ||
| CGC - GLAS | 63% Loosely correlated | -6.67% | ||
| TLRY - GLAS | 59% Loosely correlated | -3.63% | ||
| CRON - GLAS | 52% Loosely correlated | +3.35% | ||
| ACB - GLAS | 50% Loosely correlated | -0.25% | ||
More | ||||
A.I.dvisor indicates that over the last year, TRLV has been closely correlated with CGC. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if TRLV jumps, then CGC could also see price increases.
| Ticker / NAME | Correlation To TRLV | 1D Price Change % | ||
|---|---|---|---|---|
| TRLV | 100% | +1.95% | ||
| CGC - TRLV | 67% Closely correlated | -6.67% | ||
| GLAS - TRLV | 65% Loosely correlated | -0.43% | ||
| TLRY - TRLV | 58% Loosely correlated | -3.63% | ||
| ACB - TRLV | 56% Loosely correlated | -0.25% | ||
| CRON - TRLV | 55% Loosely correlated | +3.35% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| TCAN | 19.41 | 1.71 | +9.67% |
| 21Shares Canton Network ETF (TCAN) | |||
| PIZ | 50.58 | 0.47 | +0.94% |
| Invesco Dorsey Wright Developed Markets Momentum ETF (PIZ) | |||
| BSMC | 39.65 | 0.16 | +0.41% |
| Brandes U.S. Small-Mid Cap Value ETF (BSMC) | |||
| MEM | 40.60 | 0.05 | +0.12% |
| Matthews Emerging Markets Equity Active ETF (MEM) | |||
| INDA | 47.27 | -0.51 | -1.07% |
| iShares MSCI India ETF (INDA) | |||